Prev Arrow Stocks

Tilray Inc. ($TLRY) Stock Forecast: Up 8.5% Today

Morpher AI identified a bullish signal. The stock price may continue to rise based on the momentum of the good news.

What is Tilray Inc.?

Tilray Brands (NASDAQ: TLRY) is a cannabis company that has been experiencing volatility in the stock market due to factors such as earnings reports, product launches, and legal disputes.

Why is Tilray Inc. going up?

TLRY stock is up 8.5% on Apr 14, 2026 15:06

  • The stock had a strong bullish movement today, closing 4.5% higher at $6.75.
  • This positive momentum could be attributed to the recent launch of PORTAL™, a new high-intensity cannabis brand targeting experienced consumers in Canada, filling a market gap and potentially driving investor optimism.
  • Despite facing legal challenges, such as the $11.3 million lawsuit from the Bob Marley estate over licensing royalties, Tilray's strategic product offerings and market expansion efforts seem to have resonated positively with investors, leading to today's bullish market movement.

TLRY Price Chart

TLRY Technical Analysis

TLRY News

Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.2% - Should You Sell?

Tilray Brands (NASDAQ:TLRY) saw its stock price decline by 2.2% to $6.57, with trading volume significantly below average. Analysts generally have a "Hold" rating on the stock, with an average price target of $11.50, though some firms have recently lowered their targets. The company reported a Q1 EPS miss and continues to show weak profitability metrics.

https://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-stock-price-down-22-should-you-sell-2026-04-10/

0 News Article Image Tilray Brands (NASDAQ:TLRY) Stock Price Down 2.2% - Should You Sell?

Tilray Brands Inc. stock falls Friday, underperforms market

Tilray Brands Inc. (TLRY) shares fell 2.23% on Friday, closing at $6.57. This drop occurred during a mixed trading session where the NASDAQ Composite Index rose and the Dow Jones Industrial Average fell. This marks the second consecutive day of losses for Tilray Brands Inc. stock.

https://www.marketwatch.com/data-news/tilray-brands-inc-stock-falls-friday-underperforms-market-f96001f0-0869ed0cc934?mod=mw_quote_news

1 News Article Image Tilray Brands Inc. stock falls Friday, underperforms market

Tilray Brands (NASDAQ:TLRY) Trading 4.5% Higher - Should You Buy?

Tilray Brands (NASDAQ:TLRY) shares recently traded up 4.5% to $6.75 on Wednesday, though with lower than average trading volume. Analysts are currently mixed on the stock, holding a consensus "Hold" rating with an average price target of $11.20, despite the company missing EPS estimates but beating revenue expectations in its latest earnings report. The cannabis company remains unprofitable and has a negative net margin.

https://www.marketbeat.com/instant-alerts/tilray-brands-nasdaqtlry-trading-45-higher-should-you-buy-2026-04-08/

2 News Article Image Tilray Brands (NASDAQ:TLRY) Trading 4.5% Higher - Should You Buy?

Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

Tilray Brands has launched PORTAL™, a new cannabis brand targeting experienced, high-tolerance consumers in Canada. The brand focuses on high-potency infused pre-rolls and liquid diamond vapes, engineered for consistency and intense performance. This launch aims to fill a market gap by offering products with uncompromising potency and a distinct sci-fi-inspired identity.

https://www.sahmcapital.com/news/content/tilray-expands-canadian-cannabis-portfolio-with-launch-of-portal-a-new-high-intensity-brand-for-the-experienced-consumer-2026-04-08

3 News Article Image Tilray Expands Canadian Cannabis Portfolio with Launch of PORTAL™, A New High Intensity Brand for the Experienced Consumer

Bob Marley Estate Sues Tilray Brand Cannabis Company For $11.3M

The Bob Marley estate has filed an $11.3 million lawsuit against Tilray Brand Inc., alleging the cannabis company owes licensing royalties for the Marley Natural brand. The estate claims Tilray engaged in a "scheme to defraud" by shifting liability for payments to an empty business entity after acquiring the original partner. Tilray disputes this, arguing its primary entities are not bound by the original agreement following corporate restructuring.

https://www.blackenterprise.com/bob-marley-estate-sues-tilray-brand-cannabis-company-for-11-3m/

4 News Article Image Bob Marley Estate Sues Tilray Brand Cannabis Company For $11.3M

Tilray Inc. Price History

02.03.2026 - TLRY Stock was up 6.5%

  • Strong Q3 earnings and a surge in international cannabis revenue contributed to Tilray exceeding revenue expectations, prompting a positive market response.
  • Analysts raised their rating on Tilray to Buy, setting a price target of $10, and expressed optimism about the company's future growth potential.
  • Despite the favorable earnings, concerns over varying margin trends, uncertainty in EPS reporting, and analyst downgrades caused a brief 5.1% decrease in the stock price after the earnings release, revealing the difficulties in maintaining consistent profitability amid revenue growth.

02.03.2026 - TLRY Stock was up 5.4%

  • Despite achieving record Q3 revenue of $206.7 million, Tilray's stock declined by 5.1% due to concerns about mixed margin trends, confusion around EPS reporting, and analyst downgrades.
  • The company's efforts in international cannabis revenue growth and strategic acquisitions were somewhat overshadowed by difficulties in converting top-line growth into consistent profit enhancements.
  • Investors have reservations concerning a notable adjusted EPS shortfall, ongoing shareholder dilution, and slow advancements in U.S. cannabis rescheduling, which have influenced market perceptions despite the positive revenue outcome.
  • Tilray's stock performance fell short of market expectations, closing well below its 52-week high, reflecting investor sentiment towards the company's financial performance and growth strategies.

07.03.2026 - TLRY Stock was down 5.1%

  • Despite a positive day in the broader market, Tilray's stock faced a downward trend, closing at $6.66.
  • Analysts hold differing views on Tilray, resulting in a consensus "Hold" rating and an average price target of $11.20. This reflects uncertainty regarding the company's future profitability.
  • Investors have expressed concerns about Tilray's persistent operational losses, narrow margins, and high expenses, leading to a substantial 97% decline in the stock value over the past five years.
  • The recent uptick in Tilray's stock price is possibly linked to short-term positive momentum driven by operational advancements in Q3. However, technical analysis indicates a consolidation range between $6.50 and $7.00, with potential downside risks due to the absence of strong buy signals.

01.03.2026 - TLRY Stock was down 5.1%

  • Despite reporting record Q3 revenue of $206.7 million, Tilray's stock experienced a bearish movement due to concerns over a significant adjusted EPS miss, continuous shareholder dilution, and slow progress in U.S. cannabis rescheduling.
  • The surge in international cannabis sales by 73% sparked a rally in Tilray's shares, but the narrowed net loss that still missed consensus might have contributed to the overall bearish sentiment.
  • Anticipation of strong Q3 earnings, a new product launch, and decreased short interest led to a premarket surge in Tilray's stock, indicating short-term gains amidst a longer-term downtrend.
  • Investors are eagerly waiting for revenue growth to translate into sustainable profitability for Tilray, as the company navigates through challenges and opportunities in the cannabis market.

30.02.2026 - TLRY Stock was down 5.2%

  • Despite beating quarterly EPS and revenue estimates, Tilray's stock saw a significant dip, possibly due to concerns about the company's profitability and negative EPS forecasts for the current year.
  • The lawsuit filed by Bob Marley's heirs against Tilray for unpaid licensing fees may have added to investor uncertainty and contributed to the bearish movement of the stock.
  • The partnership announcement with Popsicle to launch new alcoholic beverages could have been overshadowed by the negative market sentiment, failing to provide a positive impact on the stock price.
  • Analysts' adjustments to price targets and earnings estimates, along with the overall market downturn, likely influenced investors to sell off Tilray shares, leading to the underperformance of the stock.

26.02.2026 - TLRY Stock was down 5.2%

  • Concerns arose among investors due to Tilray's partnership with Popsicle to launch "Popsicle Hard" beverages, potentially affecting its core business focus.
  • The anticipation of Tilray's third-quarter fiscal year 2026 financial results on April 1, 2026, could be causing uncertainty and volatility in the stock.
  • Investor caution regarding the financial results may lead to a sell-off of Tilray stock in expectation of disappointing earnings or guidance.
  • The absence of specific positive updates or catalysts may be contributing to the bearish sentiment surrounding Tilray's stock today.

25.02.2026 - TLRY Stock was up 6.6%

  • The increase in Tilray's stock price is likely the result of oversold conditions, leading to short-term optimism among investors.
  • Anticipation for the upcoming third fiscal quarter results scheduled for April 1, 2026, has contributed to positive market sentiment.
  • Despite facing profitability challenges with a negative net margin, recent company activities such as acquiring BrewDog U.S. assets and expanding medical cannabis partnerships have bolstered investor confidence.
  • Analyst opinions on the stock vary, with a consensus "Hold" rating; however, the temporary rebound suggests that investors are cautiously positive about Tilray's future prospects.

25.02.2026 - TLRY Stock was up 8.2%

  • TLRY stock rose by 3.57% to $6.68 today, following recent bearish trends, despite trading below significant moving averages.
  • The stock's uptick may be linked to oversold conditions identified by certain technical indicators, attracting short-term investors seeking opportunities.
  • Uncertainty over U.S. federal cannabis rescheduling discussions continues to impact investor sentiment, contributing to the stock's volatility.
  • TLRY's recent acquisition of craft brewer BrewDog and CEO Irwin Simon's plans to revitalize the brand through expansion efforts may have also influenced the positive market movement, highlighting the company's commitment to diversification and growth strategies.

14.03.2026 - TLRY Stock was up 8.5%

  • The stock had a strong bullish movement today, closing 4.5% higher at $6.75.
  • This positive momentum could be attributed to the recent launch of PORTAL™, a new high-intensity cannabis brand targeting experienced consumers in Canada, filling a market gap and potentially driving investor optimism.
  • Despite facing legal challenges, such as the $11.3 million lawsuit from the Bob Marley estate over licensing royalties, Tilray's strategic product offerings and market expansion efforts seem to have resonated positively with investors, leading to today's bullish market movement.

27.02.2026 - TLRY Stock was down 5.0%

  • Concerns arose among investors over Tilray's decision to enter the alcoholic ready-to-drink beverages market through a licensing agreement with The Magnum Ice Cream Company.
  • The upcoming quarterly earnings report, along with predictions of a potential EPS loss despite revenue growth from new beverage products, contributed to the negative market sentiment.
  • The general market downturn, as evidenced by declines in the NASDAQ Composite Index and the Dow Jones Industrial Average, influenced the selling pressure on Tilray stock.
  • Despite recent positive developments such as new partnerships and product launches, Tilray's stock struggled to surpass key moving averages, and conflicting analyst opinions may have fueled the downward trajectory.

13.03.2026 - TLRY Stock was up 5.2%

  • Despite recent declines in the stock price and mixed trading sessions, today's bullish movement suggests a potential shift in investor sentiment.
  • The launch of PORTAL™, a new high-intensity cannabis brand targeting experienced consumers, could have positively impacted the stock price as it signals the company's efforts to expand its product offerings and cater to specific market segments.
  • The ongoing legal battle with the Bob Marley estate over licensing royalties might have initially caused uncertainty among investors, leading to the recent declines. However, the bullish movement today could indicate that investors are optimistic about a potential resolution or are focusing more on the company's product innovations.
  • It's essential for investors to closely monitor any updates regarding the legal dispute and the company's financial performance to make informed decisions about their investments in Tilray Brands Inc.

31.02.2026 - TLRY Stock was up 5.3%

  • The launch of Shock Top's "High Voltage" beer with bold orange flavors and a 9.6% ABV has created market buzz. However, investor focus appears to be more on the company's financial standing.
  • Despite Tilray surpassing quarterly estimates, analysts have downgraded the stock to a "Hold" and reduced price targets, indicating concerns about profitability and financial well-being.
  • The forthcoming earnings report on April 1st will be a key factor in shaping the stock's future direction, with investors eager to see if Tilray's financial performance shows any signs of recovery.
  • Despite prevailing pessimism, the rise in institutional investors' holdings in the cannabis firm suggests enduring confidence in Tilray's growth prospects, potentially offering some stability to the stock in the short term.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.